Mismatch repair hMSH2, hMLH1, hMSH6 and hPMS2 mRNA expression profiles in precancerous and cancerous urothelium

Vageli,Dimitra  P.; Giannopoulos,Stavros; Doukas,Sotirios  G.; Kalaitzis,Christos; Giannakopoulos,Stilianos; Giatromanolaki,Alexandra; Koukoulis,George  K.; Touloupidis,Stavros

doi:10.3892/ol.2012.979

Mismatch repair hMSH2, hMLH1, hMSH6 and hPMS2 mRNA expression profiles in precancerous and cancerous urothelium

Authors:
- Dimitra P. Vageli
- Stavros Giannopoulos
- Sotirios G. Doukas
- Christos Kalaitzis
- Stilianos Giannakopoulos
- Alexandra Giatromanolaki
- George K. Koukoulis
- Stavros Touloupidis
View Affiliations

Affiliations: Department of Pathology, Medical School, University of Thessaly, Larissa, Thessaly 41110, Greece, Department of Urology, Medical School, Democritus University of Thrace and University Hospital of Alexandroupolis, Alexandroupolis 68100, Greece, Department of Pathology, Medical School, Democritus University of Thrace and University Hospital of Alexandroupolis, Alexandroupolis 68100, Greece
Published online on: October 19, 2012 https://doi.org/10.3892/ol.2012.979
Pages: 283-294

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Changes in the expression of the mismatch repair (MMR) genes hMSH2, hMLH1, hMSH6 and hPMS2 reflect dysfunction of the DNA repair system that may allow the malignant transformation of tissue cells. The aim of the present study was to address the mRNA expression profiles of the mismatch DNA repair system in cancerous and precancerous urothelium. This is the first study to quantify MMR mRNA expression by applying quantitative real-time PCR (qPCR) and translate the results to mRNA phenotypic profiles (r, reduced; R, regular or elevated) in bladder tumors [24 urothelial cell carcinomas (UCCs) and 1 papillary urothelial neoplasm of low malignant potential (PUNLMP)] paired with their adjacent normal tissues (ANTs). Genetic instability analysis was applied at polymorphic sites distal or close to the hMSH2 and hMLH1 locus. Presenting our data, reduced hMSH2, hMSH6 and hPMS2 mRNA expression profiles were observed in cancerous and precancerous urothelia. Significantly, the ANTs of UCCs revealed the highest percentages of reduced hMSH2 (r2), hMSH6 (r6) and hPMS2 (p2) mRNA phenotypes relative to their tumors (P<0.03). In particular, combined r2r6 (P<0.02) presented a greater difference between ANTs of low‑grade UCCs vs. their tumors compared with ANTs of high‑grade UCCs (P=0.000). Reduced hMLH1 (r1) phenotype was not expressed in precancerous or cancerous urothelia. The hMSH6 mRNA was the most changed in UCCs (47.8%), while hMSH2, hMLH1 and hPMS2 showed overexpression (47.8, 35 and 30%, respectively) that was associated with gender and histological tumor grading or staging. Genetic instability was rare in polymorphic regions distal to hMLH1. Our data reveal a previously unrecognized hMSH2 and hMSH6 mRNA combined phenotype (r2r6) correlated with a precancerous urothelium and show that hMLH1 is transcriptionally activated in precancerous or cancerous urothelium. In the present study, it is demonstrated that reduction of hMSH6 mRNA is a frequent event in bladder tumorigenesis and reflects a common mechanism of suppression with hMSH2, while alterations of hMSH2 or hMLH1 mRNA expression in UCCs does not correlate with the allelic imbalance of polymorphic regions harboring the genes.

View Figures

View References

1	Lee TK, Chaux A, Karram S, Miyamoto H, Miller JS, Fajardo DA, Epstein JI and Netto GJ: Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center. Hum Pathol. 42:1799–1803. 2011. View Article : Google Scholar : PubMed/NCBI
2	MacLennan GT, Kirkali Z and Cheng L: Histologic grading of noninvasive papillary urothelial neoplasms. Eur Urol. 51:889–898. 2007. View Article : Google Scholar : PubMed/NCBI
3	Chaux A, Karram S, Miller JS, Fajardo DA, Lee TK, Miyamoto H and Netto GJ: High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center. Hum Pathol. 43:115–120. 2012. View Article : Google Scholar
4	Cheng L, Davidson DD, Maclennan GT, Williamson SR, Zhang S, Koch MO, Montironi R and Lopez-Beltran A: The origins of urothelial carcinoma. Expert Rev Anticancer Ther. 10:865–880. 2010. View Article : Google Scholar : PubMed/NCBI
5	Cordon-Cardo C, Cote RJ and Sauter G: Genetic and molecular markers of urothelial premalignancy and malignancy. Scand J Urol Nephrol. (Suppl 205): 82–93. 2000. View Article : Google Scholar : PubMed/NCBI
6	Cohen SM: Urinary bladder carcinogenesis. Toxicol Pathol. 26:121–127. 1998. View Article : Google Scholar
7	Vageli D, Kiaris H, Delakas D, Anezinis P, Cranidis A and Spandidos DA: Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors. Cancer Lett. 107:241–247. 1996. View Article : Google Scholar : PubMed/NCBI
8	Preston BD, Albertson TM and Herr AJ: DNA replication fidelity and cancer. Semin Cancer Biol. 20:281–293. 2010. View Article : Google Scholar : PubMed/NCBI
9	Umar A and Kunkel TA: DNA-replication fidelity, mismatch repair and genome instability in cancer cells. Eur J Biochem. 238:297–307. 1996. View Article : Google Scholar : PubMed/NCBI
10	Marti TM, Kunz C and Fleck O: DNA mismatch repair and mutation avoidance pathways. J Cell Physiol. 191:28–41. 2002. View Article : Google Scholar : PubMed/NCBI
11	Acharya S, Wilson T, Gradia S, Kane MF, Guerrette S, Marsischky GT, Kolodner R and Fishel R: hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc Natl Acad Sci USA. 93:13629–13634. 1996. View Article : Google Scholar : PubMed/NCBI
12	Genschel J, Littman SJ, Drummond JT and Modrich P: Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha. J Biol Chem. 273:19895–19901. 1998. View Article : Google Scholar : PubMed/NCBI
13	Umar A, Risinger JI, Glaab WE, Tindall KR, Barrett JC and Kunkel TA: Functional overlap in mismatch repair by human MSH3 and MSH6. Genetics. 148:1637–1646. 1998.PubMed/NCBI
14	Nakagawa T, Datta A and Kolodner RD: Multiple functions of MutS- and MutL-related heterocomplexes. Proc Natl Acad Sci USA. 96:14186–14188. 1999. View Article : Google Scholar : PubMed/NCBI
15	Ruszkiewicz A, Bennett G, Moore J, Manavis J, Rudzki B, Shen L and Suthers G: Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology. 34:541–547. 2002. View Article : Google Scholar : PubMed/NCBI
16	Vageli D, Daniil Z, Dahabreh J, Karagianni E, Vamvakopoulou DN, Ioannou MG, Scarpinato K, Vamvakopoulos NC, Gourgoulianis KI and Koukoulis GK: Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas. Lung Cancer. 64:282–288. 2009. View Article : Google Scholar : PubMed/NCBI
17	Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R and Rüschoff J: Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res. 57:4749–4756. 1997.PubMed/NCBI
18	Mylona E, Zarogiannos A, Nomikos A, Giannopoulou I, Nikolaou I, Zervas A and Nakopoulou L: Prognostic value of microsatellite instability determined by immunohistochemical staining of hMSH2 and hMSH6 in urothelial carcinoma of the bladder. APMIS. 116:59–65. 2008. View Article : Google Scholar : PubMed/NCBI
19	Yamamoto Y, Matsuyama H, Kawauchi S, Furuya T, Liu XP, Ikemoto K, Oga A, Naito K and Sasaki K: Biological characteristics in bladder cancer depend on the type of genetic instability. Clin Cancer Res. 12:2752–2758. 2006. View Article : Google Scholar : PubMed/NCBI
20	Catto JW, Xinarianos G, Burton JL, Meuth M and Hamdy FC: Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. Int J Cancer. 105:484–490. 2003. View Article : Google Scholar : PubMed/NCBI
21	Rubio J, Blanes A, Sanchez-Carrillo JJ and Diaz-Cano SJ: Microsatellite abnormalities and somatic down-regulation of mismatch repair characterize nodular-trabecular muscle-invasive urothelial carcinoma of the bladder. Histopathology. 51:458–467. 2007. View Article : Google Scholar
22	Ericson KM, Isinger AP, Isfoss BL and Nilbert MC: Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma. BMC Cancer. 5:232005. View Article : Google Scholar : PubMed/NCBI
23	Saetta AA, Goudopoulou A, Korkolopoulou P, Voutsinas G, Thomas-Tsagli E, Michalopoulos NV and Patsouris E: Mononucleotide markers of microsatellite instability in carcinomas of the urinary bladder. Eur J Surg Oncol. 30:796–803. 2004. View Article : Google Scholar : PubMed/NCBI
24	Kassem HS, Varley JM, Hamam SM and Margison GP: Immunohistochemical analysis of expression and allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder cancer. Br J Cancer. 84:321–328. 2001. View Article : Google Scholar : PubMed/NCBI
25	Thykjaer T, Christensen M, Clark AB, Hansen LR, Kunkel TA and Ørntoft TF: Functional analysis of the mismatch repair system in bladder cancer. Br J Cancer. 85:568–575. 2001. View Article : Google Scholar : PubMed/NCBI
26	Leach FS, Hsieh JT, Molberg K, Saboorian MH, McConnell JD and Sagalowsky AI: Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy. Cancer. 88:2333–2341. 2000. View Article : Google Scholar : PubMed/NCBI
27	Vageli D, Ioannou MG and Koukoulis GK: Transcriptional activation of hTERT in breast carcinomas by the Her2-ER81-related pathway. Oncol Res. 17:413–423. 2009. View Article : Google Scholar : PubMed/NCBI
28	Wang YC, Lu YP, Tseng RC, Lin RK, Chang JW, Chen JT, Shih CM and Chen CY: Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. J Clin Invest. 111:887–895. 2003. View Article : Google Scholar : PubMed/NCBI
29	Zhou XP, Hoang JM, Cottu P, Thomas G and Hamelin R: Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors. Oncogene. 15:1713–1718. 1997. View Article : Google Scholar : PubMed/NCBI
30	Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G and Hamelin R: BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res. 57:300–303. 1997.PubMed/NCBI
31	Vageli D, Daniil Z, Dahabreh J, Karagianni E, Liloglou T, Koukoulis G and Gourgoulianis K: Microsatellite instability and loss of heterozygosity at the MEN1 locus in lung carcinoid tumors: a novel approach using real-time PCR with melting curve analysis in histopathologic material. Oncol Rep. 15:557–564. 2006.
32	Ericson KM, Isinger AP, Isfoss BL and Nilbert MC: Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma. BMC Cancer. 5:232005. View Article : Google Scholar : PubMed/NCBI
33	Shcherbakova PV, Hall MC, Lewis MS, Bennett SE, Martin KJ, Bushel PR, Afshari CA and Kunkel TA: Inactivation of DNA mismatch repair by increased expression of yeast MLH1. Mol Cell Biol. 21:940–951. 2001. View Article : Google Scholar : PubMed/NCBI
34	Mao G, Lee S, Ortega J, Gu L and Li GM: Modulation of microRNA processing by mismatch repair protein MutLα. Cell Res. 22:973–985. 2012.PubMed/NCBI
35	Chang DK, Ricciardiello L, Goel A, Chang CL and Boland CR: Steady-state regulation of the human DNA mismatch repair system. J Biol Chem. 275:18424–18431. 2000. View Article : Google Scholar
36	Köster F, Schröer A, Fischer D, Greweldinger T, Diedrich K and Friedrich M: Correlation of DNA mismatch repair protein hMSH2 immunohistochemistry with p53 and apoptosis in cervical carcinoma. Anticancer Res. 27:63–68. 2007.PubMed/NCBI
37	Hayes AP, Sevi LA, Feldt MC, Rose MD and Gammie AE: Reciprocal regulation of nuclear import of the yeast MutSalpha DNA mismatch repair proteins Msh2 and Msh6. DNA Repair (Amst). 8:739–751. 2009. View Article : Google Scholar : PubMed/NCBI
38	Bonnal C, Ravery V, Toublanc M, Bertrand G, Boccon-Gibod L, Henin D, et al: Absence of microsatellite instability in transitional cell carcinoma of the bladder. Urology. 55:287–291. 2000. View Article : Google Scholar : PubMed/NCBI